Your browser doesn't support javascript.
loading
Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease.
Caron, Nicholas S; Banos, Raul; Yanick, Christopher; Aly, Amirah E; Byrne, Lauren M; Smith, Ethan D; Xie, Yuanyun; Smith, Stephen E P; Potluri, Nalini; Findlay Black, Hailey; Casal, Lorenzo; Ko, Seunghyun; Cheung, Daphne; Kim, Hyeongju; Seong, Ihn Sik; Wild, Edward J; Song, Ji-Joon; Hayden, Michael R; Southwell, Amber L.
Afiliación
  • Caron NS; Centre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital Research Institute, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada.
  • Banos R; Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32828.
  • Yanick C; Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32828.
  • Aly AE; Centre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital Research Institute, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada.
  • Byrne LM; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, United Kingdom.
  • Smith ED; Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32828.
  • Xie Y; Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32828.
  • Smith SEP; Seattle Children's Research Institute, Center for Integrative Brain Research, Seattle, Washington 98101.
  • Potluri N; Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32828.
  • Findlay Black H; Centre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital Research Institute, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada.
  • Casal L; Centre for Molecular Medicine and Therapeutics, Vancouver, British Columbia V5Z 4H4, Canada.
  • Ko S; Centre for Molecular Medicine and Therapeutics, Vancouver, British Columbia V5Z 4H4, Canada.
  • Cheung D; Centre for Molecular Medicine and Therapeutics, Vancouver, British Columbia V5Z 4H4, Canada.
  • Kim H; Department of Biological Sciences, KAIST, Daejeon, Korea, 34141.
  • Seong IS; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts 02114.
  • Wild EJ; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, United Kingdom.
  • Song JJ; Department of Biological Sciences, KAIST, Daejeon, Korea, 34141.
  • Hayden MR; Centre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital Research Institute, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada amber.southwell@ucf.edu mrh@cmmt.ubc.ca.
  • Southwell AL; Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32828 amber.southwell@ucf.edu mrh@cmmt.ubc.ca.
J Neurosci ; 41(4): 780-796, 2021 01 27.
Article en En | MEDLINE | ID: mdl-33310753
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Química Encefálica / Enfermedad de Huntington / Proteína Huntingtina Límite: Animals / Female / Humans / Male Idioma: En Revista: J Neurosci Año: 2021 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Química Encefálica / Enfermedad de Huntington / Proteína Huntingtina Límite: Animals / Female / Humans / Male Idioma: En Revista: J Neurosci Año: 2021 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos